These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8233090)

  • 21. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease.
    Inaguma Y; Shinohara H; Inagaki T; Kato K
    J Neurol Sci; 1992 Jul; 110(1-2):57-61. PubMed ID: 1506869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Mar; 606(1):10-8. PubMed ID: 8096426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of parvalbumin-immunoreactive cells and fibers in the monkey temporal lobe: the hippocampal formation.
    Pitkänen A; Amaral DG
    J Comp Neurol; 1993 May; 331(1):37-74. PubMed ID: 8320348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC; Kosik KS; Kowall NW
    Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of the effects of Alzheimer's plaques on living neurons.
    Carpenter MK; Crutcher KA; Kater SB
    Neurobiol Aging; 1993; 14(3):207-15. PubMed ID: 7686640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of Alzheimer-related neuritic plaques: AT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala.
    Yilmazer-Hanke DM
    Clin Neuropathol; 1998; 17(4):194-8. PubMed ID: 9707333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
    Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease.
    Ferrer I; Soriano E; Tuñón T; Fonseca M; Guionnet N
    J Neurol Sci; 1991 Dec; 106(2):135-41. PubMed ID: 1802961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex.
    Sorvari H; Soininen H; Paljärvi L; Karkola K; Pitkänen A
    J Comp Neurol; 1995 Sep; 360(2):185-212. PubMed ID: 8522643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia.
    Arai H; Emson PC; Mountjoy CQ; Carassco LH; Heizmann CW
    Brain Res; 1987 Aug; 418(1):164-9. PubMed ID: 3311290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex.
    Erickson SL; Lewis DA
    J Comp Neurol; 2002 Jun; 448(2):186-202. PubMed ID: 12012429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
    Arnold SE; Hyman BT; Flory J; Damasio AR; Van Hoesen GW
    Cereb Cortex; 1991; 1(1):103-16. PubMed ID: 1822725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural heterogeneity in cerebral amyloid of Alzheimer's disease.
    Powers JM; Skeen JT
    Acta Neuropathol; 1988; 76(6):613-23. PubMed ID: 3201924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular changes in the brains with Alzheimer's disease.
    Yamashita K; Miyakawa T; Katsuragi S
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):79-84. PubMed ID: 1753494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-binding protein parvalbumin as a neuronal marker.
    Celio MR; Heizmann CW
    Nature; 1981 Sep; 293(5830):300-2. PubMed ID: 7278987
    [No Abstract]   [Full Text] [Related]  

  • 38. A cellular mechanism for the neuronal changes underlying Alzheimer's disease.
    Vickers JC
    Neuroscience; 1997 Jun; 78(3):629-39. PubMed ID: 9153646
    [No Abstract]   [Full Text] [Related]  

  • 39. Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology.
    Vickers JC; Chin D; Edwards AM; Sampson V; Harper C; Morrison J
    Exp Neurol; 1996 Sep; 141(1):1-11. PubMed ID: 8797662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    Siedlak SL; Jiang Y; Huntley ML; Wang L; Gao J; Xie F; Liu J; Su B; Perry G; Wang X
    J Alzheimers Dis; 2017; 58(4):1027-1033. PubMed ID: 28527219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.